Sat, Jan 24, 2015, 11:02 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • censored53 censored53 Aug 14, 2013 9:06 AM Flag

    Fewer than One in a Thousand able to afford annual 300K prescription


    United States 316,668,567 (July 2013 est.)
    European Union 503,890,016 (July 2013 est.)
    World 7,095,217,980 (July 2013 est.)

    one in a million afflicted means potential of 317 in USA, 504 in EU, or 7,095 prescriptions worldwide. How many of those do you think can afford ANNUAL 300K prescription?

    GDP per Capita
    United States $50,700 (2012 est.)
    European Union $35,100 (2012 est.)
    World $12,700 (2012 est.)

    per IRS statistics, applying affordability, the income cutoff for the top 1% of people who filed income tax returns in 2009 was 344K (1.38 million people), being generous that means approximately 1 in 200 in the USA could if they chose afford the prescription....Worldwide I'd have to assume fewer than 1 in 1000 of those afflicted could if they chose afford the prescription.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
24.87+0.36(+1.47%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Array BioPharma, Inc.
NASDAQFri, Jan 23, 2015 4:00 PM EST
Gran Tierra Energy, Inc.
AMEXFri, Jan 23, 2015 4:00 PM EST